SIGN UP
LOG IN
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·07/31/2025 17:08:07
Listen to the news
Gainers
- Soligenix (NASDAQ:SNGX) shares rose 192.0% to $3.65 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million.
- InspireMD (NASDAQ:NSPR) stock rose 22.13% to $2.89. The market value of their outstanding shares is at $72.6 million.
- Onconetix (NASDAQ:ONCO) shares increased by 21.73% to $3.91. The market value of their outstanding shares is at $1.6 million.
- SNDL (NASDAQ:SNDL) shares increased by 21.18% to $1.75. The company's market cap stands at $370.5 million. As per the press release, Q2 earnings came out today.
- Plus Therapeutics (NASDAQ:PSTV) shares moved upwards by 18.6% to $0.54. The market value of their outstanding shares is at $23.3 million.
- Jyong Biotech (NASDAQ:MENS) shares increased by 18.56% to $21.3. The company's market cap stands at $1.3 billion.
Losers
- Pulmonx (NASDAQ:LUNG) shares declined by 39.7% to $1.9 during Thursday's regular session. The company's market cap stands at $125.3 million. The company's, Q2 earnings came out yesterday.
- GRI Bio (NASDAQ:GRI) stock fell 37.35% to $1.28. The market value of their outstanding shares is at $5.1 million.
- Ontrak (NASDAQ:OTRK) shares decreased by 36.5% to $0.31. The company's market cap stands at $3.4 million.
- Align Technology (NASDAQ:ALGN) shares declined by 35.12% to $132.09. The company's market cap stands at $14.7 billion. The company's, Q2 earnings came out yesterday.
- Baxter Intl (NYSE:BAX) shares decreased by 19.12% to $22.69. The company's market cap stands at $14.3 billion. As per the press release, Q2 earnings came out today.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock declined by 15.0% to $0.67. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.